Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.
Zephyrus spun out from Dr. Amy Herr’s laboratory at U.C. Berkeley in 2013 and is affiliated with QB3, BayBio, StartX Med, a Stanford-affiliated nonprofit technology accelerator, and Berkeley Skydeck, the premier accelerator at U.C. Berkeley.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.zephyrusbio.com
Zephyrus Biosciences Questions
Zephyrus Biosciences's website is http://www.zephyrusbio.com
Zephyrus Biosciences's LinkedIn profile is https://www.linkedin.com/company/zephyrus-biosciences
Zephyrus Biosciences's industry is
Biotechnology Research
Zephyrus Biosciences's top competitors are
Eutropics,
Cytobank Inc.,
Sagemedic Corp.,
Life Science Cares New York,
Meissa Vaccines,
Newbridge Media Inc.,
Bio-Techne,
Mission Bay Capital,
Fibralign Corporation,
Be The Match Biotherapies.
Zephyrus Biosciences's categories are Biotechnology Research
